Alfa Wassermann S.p.a.

Alfasigma S.p.a.

Maria Rosaria Pantaleo

Giuseppe Claudio Viscomi

Ernesto Palazzini

Villiam Zamboni

Leone G Rotini

Patrizio Ferrari

Claudio Giuseppe Viscomi

Lorenzo Morelli

Leone Gabriele Rotini

William Zamboni

The object of the invention consists of pharmaceutical formulations containing rifaximin in the shape of microgranules made gastroresistant by an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, by their preparation and by their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel diseases (IBD) and mainly Crohn's disease.

Gastroresistant pharmaceutical formulations containing rifaximin

The disclosure refers to biologically pure cultures of two strains ofnamed W11 and W11and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.

Bifidobacteria and preparations containing them

Growing community of inventors

Bologna, Italy

Maria Rosaria Pantaleo